"本文以Brønsted酸性离子液体[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]催化吲哚与α，β-不饱和酮发生Michael加成反应，得到了一系列β-吲哚酮化合物，最高产率可达99%。离子液体催化剂循环使用3次以上，催化活性没有明显下降。该方法具有条件温和、操作简单的特点，为β-吲哚酮化合物的合成提供了一种新的方法。 关键词 :离子液体，催化，吲哚，α, β-不饱和酮，Michael加成 Copyright © 2017 by authors and Hans Publishers Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/"
"众所周知，吲哚作为一类具有独特结构和生物活性的化合物，在药物、功能材料和香料等领域应用广泛 [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] 。β-吲哚酮化合物在吲哚化学的研究中具有重要地位，迈克尔加成反应是合成该类化合物的有效途径之一 [ 6 ] [ 7 ] [ 8 ] [ 9 ] [ 10 ] 。 近年来，离子液体因具有低毒、低挥发性、良好的溶解性能和可循环使用等优点被广泛关注 [ 11 ] [ 12 ] [ 13 ] [ 14 ] 。离子液体作为反应溶剂、催化剂或促进剂应用于有机合成反应，可以高效、高选择性且条件温和的实现化合物之间的转化，符合绿色化学的理念 [ 15 ] [ 16 ] 。基于本课题组在离子液体领域的研究基础 [ 17 ] [ 18 ] ，本文采用Brønsted酸性功能化噻唑硫酮离子液体[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]催化吲哚与α，β-不饱和酮发生迈克尔加成反应，以82%~99%的产率得到了一系列β-吲哚酮化合物。本方法优点在于底物普适性好、产物产率高，催化剂可以循环使用3次以上催化活性无明显下降。"
"瑞士Buchi B-540型熔点仪；德国Bruker Equinox 55红外光谱仪(KBr压片)；美国Varian inova-400型核磁共振仪(TMS为内标，CDCl 3 、D 2 O或DMSO-d 6 为溶剂)；美国HP1100液相色谱质谱仪。所有试剂均为市售分析纯，用前未经处理直接使用。 2.2. Brønsted酸性离子液体[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]合成 Brønsted酸性离子液体[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]的合成参照文献 [ 19 ]  α，β-不饱和酮的合成参照文献 [ 20 ] 。  吲哚化合物(1 mmol)、α，β-不饱和酮化合物(1 mmol)、Brønsted酸性离子液体催化剂[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ] (10 mol%)和乙腈(5 mL)在80℃下磁力搅拌反应5 h。反应结束后，待反应混合物冷至室温，加入碎冰搅拌至碎冰溶化并析出固体，过滤，用蒸馏水洗涤固体得到粗产物。粗产物经硅胶柱层析分离纯化得到目标产物纯品，反应式如式1所示。所得化合物结构经 1 H NMR， 13 C NMR，IR和MS确征。 未知化合物的结构表征如下： 化合物3h：粉色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm): 7.99 (s, 1H), 7.90-7.92 (m, 2H), 7.92 (d, J = 7.6 Hz, 2H), 7.46-7.52 (m, 1H), 7.39 (d, J = 7.6 Hz, 1H), 7.27-7.32 (m, 1H), 7.14 (t, J = 8.0 Hz, 1H), 6.88-7.03 (m, 6H), 5.03 (t, J = 8.0 Hz, 1H), 3.84 (s, 3H), 3.60-3.76 (m, 2H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 196.91, 163.47, 162.53, 160.10, 140.01, 139.98, 136.63, 130.37, 130.12, 129.29, 129.21, 126.48, 122.23, 121.29, 119.47, 119.44, 119.33, 115.24, 115.03, 113.73, 111.15, 76.70, 55.47, 44.80, 37.64; IR (KBr), υ max /cm -1 : 3390, 3048, 2908, 2838, 1659, 1598, 1507, 1419, 1355, 1253, 1218, 1180, 1020, 980, 837, 742, 591, 534; ESI-MS: m/z (%) = 396 (100) [M+Na] + . 化合物3j：土黄色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm): 7.88 (d, J = 12.0 Hz, 3H), 6.86-7.48 (m, 10H), 4.98 (t, J = 8.0 Hz, 1H), 4.04-4.09 (m, 2H), 3.59-3.77 (m, 2H), 2.17 (s, 6H ), 1.40 (t, J = 4.0 Hz, 3H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 197.16, 162.76, 141.82, 136.59, 136.38, 134.27, 130.38, 130.10, 129.59, 129.17, 126.74, 124.97, 121.99, 121.34, 119.73, 119.61, 119.28, 114.08, 111.01, 76.69, 63.71, 44.97, 37.89, 19.89, 19.32, 14.66; IR (KBr), υ max /cm -1 : 3335, 3041, 2982, 2936, 2889, 1649, 1592, 1420, 1357, 1259, 1171, 1041, 816, 741, 610; ESI-MS: m/z (%) = 420 (100) [M+Na] + . 化合物3k：紫红色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm): 8.05 (s, 1H), 7.87-7.91 (m, 2H), 6.86-7.50 (m, 10H), 5.01 (s, 1H), 4.04-4.10 (m, 2H), 3.56-3.75 (m, 2H), 1.41 (t, J = 8.0 Hz, 3H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 196.46, 163.02, 158.75, 156.30, 141.95, 141.92, 136.63, 132.64, 130.37, 129.77, 128.45, 128.37, 126.33, 122.36, 121.31, 119.59, 119.28, 118.67, 116.29, 116.07, 114.22, 111.24, 108.93, 108.72, 76.71, 63.79, 44.57, 37.34, 14.65; IR (KBr), υ max /cm -1 : 3331, 3058, 2983, 2935, 2895, 1645, 1598, 1493, 1334, 1246, 1172, 1042, 980, 813, 738, 612; ESI-MS: m/z (%) = 490 (100) [M+Na] + . 化合物3l：淡黄色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm): 7.92-7.99 (m, 2H), 6.80-7.39 (m, 9H), 5.46 (t, J = 8.0 Hz, 1H), 4.06-4.11 (m, 2H), 3.72-3.84 (m, 1H), 3.53-3.76 (m, 2H), 1.55 (s, 1H), 1.41 (t, J = 8.0 Hz, 3H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 196.56, 141.28, 137.40, 137.29, 136.69, 136.58, 134.57, 133.14, 130.17, 129.69, 129.07, 127.10, 126.87, 126.14, 124.83, 121.72, 119.48, 118.90, 117.74, 109.31, 109.21, 76.69, 45.42, 37.78, 32.69, 19.91, 19.34; IR (KBr), υ max /cm -1 : 3384, 3059, 2980, 1652, 1598, 1484, 1340, 1248, 1173, 1041, 907, 844, 742, 640; ESI-MS: m/z (%) = 444 (100) [M+Na] + . Scheme 1. Synthesis of β-indolone compounds 式1. β-吲哚酮化合物的合成 化合物3m：褐色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.94 (s, 2H), 7.71 (d, J = 8.0 Hz, 1H), 7.00-7.06 (m, 9H), 4.98 (t, J = 8.0 Hz, 1H), 3.61-3.75 (m, 2H), 2.18 (s, 6H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 196.57, 196.02, 141.09, 137.43, 136.68, 136.57, 134.62, 133.15, 130.61, 130.15, 129.69, 129.06, 127.09, 126.51, 124.88, 122.20, 121.28, 119.46, 111.10, 58.49, 45.27, 37.89, 19.90, 19.33; IR (KBr), υ max /cm -1 : 3393, 3040, 2922, 1677, 1580, 1453, 1387, 1276, 1190, 1026, 880, 802, 741, 523; ESI-MS: m/z (%) = 444 (45) [M+Na] + . 化合物3o：淡粉色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.91-7.94 (m, 2H), 7.16-7.57 (m, 7H), 7.24 (t, J = 3.6 Hz, 1H), 6.99-7.03 (m, 1H), 6.90-6.95 (m, 2H), 6.83 (s, 1H), 5.02 (t, J = 8.0 Hz, 1H), 3.75 (d, J = 9.6 Hz, 2H), 3.74 (s, 3H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 196.57, 141.09, 137.43, 136.68, 136.57, 134.62, 133.15, 130.61, 130.15, 129.69, 129.06, 127.09, 126.51, 124.88, 122.20, 121.28, 119.46, 119.27, 111.10, 76.69, 45.27, 37.89, 19.90, 19.33; IR (KBr), υ max /cm -1 : 3058, 2878, 1673, 1569, 1505, 1448, 1308, 1223, 1155, 1012, 976, 830, 742, 690; ESI-MS: m/z (%) = 380 (100) [M+Na] + . 化合物3q：草绿色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.92 (d, J = 7.6 Hz, 2H), 7.46-7.52 (m, 4H), 7.19-7.32 (m, 5H), 7.11-7.15 (m, 1H), 7.01 (t, J = 1.6 Hz, 1H), 6.84 (s, 1H), 5.12-5.16 (m, 1H), 3.74 (s, 3H), 3.32-3.3.52 (m, 2H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 188.35, 164.42, 163.01, 161.89, 138.54, 138.53, 136.34, 136.23, 130.92, 130.50, 129.86, 129.83, 129.07, 128.98, 124.37, 124.34, 117.69, 117.44, 114.81, 114.59, 114.31, 76.69, 63.80, 14.67.; IR (KBr), υ max /cm -1 : 3056, 2909, 2823, 1673, 1592, 1471, 1371, 1237, 1196, 1071, 998, 881, 737, 686; ESI-MS: m/z (%) = 442 (100) [M+Na] + . 化合物3t：土黄色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.75-7.79 (m, 2H), 7.54-7.57 (m, 2H), 7.43 (d, J = 8.0 Hz, 1H), 7.14-7.35 (m, 7H), 6.99-7.03 (m, 1H), 6.81 (s, 1H), 5.02 (t, J = 8.0 Hz, 1H), 3.73-3.79 (m, 2H), 3.72 (s, 3H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 197.54, 144.10, 137.30, 135.80, 131.83, 129.61, 128.45, 128.12, 127.72, 126.87, 126.33, 126.18, 121.73, 119.50, 118.89, 117.58, 109.30, 109.22, 45.22, 38.17, 32.71; IR (KBr), υ max /cm -1 : 3054, 2885, 1679, 1580, 1481, 1397, 1243, 1194, 1069, 972, 828, 740, 697; ESI-MS: m/z (%) = 442 (75) [M+Na] + . 化合物3u：粉色粉末； 1 H NMR (CDCl 3 , 400 MHz, TMS): δ (ppm) : 7.83-7.85 (m, 2H), 7.16-7.43 (m, 7H), 7.01 (t, J = 7.6 Hz, 1H), 6.77-6.80 (m, 3H), 4.97 (t, J = 8.0 Hz, 1H), 3.74 (s, 3H), 3.71 (s, 3H), 3.62-3.70 (m, 2H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 188.07, 146.42, 140.47, 137.96, 137.35, 137.09, 133.19, 132.12, 130.68, 130.41, 130.32, 129.77, 127.48, 126.38, 119.66, 76.68, 19.95, 19.77; IR (KBr), υ max /cm -1 : 3050, 2934, 2834, 1677, 1585, 1508, 1466, 1250, 1173, 1092, 1035, 1009, 976, 829, 802, 740; 7.88-7.92 (d, 2H, CH), 7.18-7.21 (d, 2H, CH), 7.04-7.06 (d, 2H, CH); ESI-MS: m/z (%) = 426 (98) [M+Na] + . 化合物3v：粉色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.75 (d, J = 8.8 Hz, 2H), 7.53 (d, J = 8.8 Hz, 2H), 7.46 (d, J = 8.0 Hz, 1H), 6.99-7.25 (m, 7H), 6.79 (s, 1H), 3.62-3.66 (m, 2H), 3.76 (s, 3H), 2.18 (s, 6H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 197.64, 141.50, 137.27, 136.47, 135.86, 134.42, 131.77, 129.62, 129.08, 128.00, 126.92, 126.12, 124.82, 121.63, 119.50, 118.81, 117.89, 109.15, 77.30, 77.19, 76.99, 76.67, 45.36, 37.71, 32.67, 19.89, 19.32; IR (KBr), υ max /cm -1 : 3044, 2915, 1677, 1580, 1478, 1377, 1248, 1197, 1069, 1004, 975, 816, 744; ESI-MS: m/z (%) = 468 (100) [M+Na] + . 化合物3w：粉色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.92-7.96 (m, 2H), 6.80-7.41 (m, 10H), 5.46 (t, J = 8.0 Hz, 1H), 4.09 (dd, 2H, J = 12.0, 7.2 Hz), 3.73-3.75 (m, 1H), 3.72 (s, 3H), 3.54-3.60 (m, 1H), 1.45 (s, 3H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 196.30, 162.91, 162.01, 159.54, 137.87, 137.83, 137.29, 133.97, 133.87, 130.40, 129.89, 129.81, 129.69, 126.92, 126.55, 121.79, 119.42, 118.94, 116.94, 116.70, 116.16, 114.14, 113.93, 109.19, 76.66, 63.73, 43.95, 34.36, 32.75, 14.65; IR (KBr), υ max /cm -1 : 3051, 2981, 2902, 1668, 1599, 1483, 1315, 1244, 1177, 1040, 904, 846, 745, 600; ESI-MS: m/z (%) = 458 (100) [M+Na] + . 化合物3x：砖红色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.89-7.92 (m, 2H), 7.46 (d, J = 8.0 Hz, 1H), 6.86-7.25 (m, 8H), 6.80 (s, 1H), 4.97 (t, J = 8.0 Hz, 1H), 4.07 (d, J = 7.2 Hz, 2H), 3.61-3.75 (m, 5H), 2.18 (s, 6H), 1.42 (t, J = 7.2 Hz, 3H); 13 C NMR (CDCl 3 , 100 MHz):δ (ppm) : 197.08, 162.73, 141.97, 137.28, 136.37, 134.21, 130.37, 130.08, 129.58, 129.16, 127.06, 126.16, 124.90, 121.51, 119.64, 118.70, 118.24, 114.04, 109.08, 76.68, 63.69, 45.08, 37.73, 32.67, 19.91, 19.34, 14.67; IR (KBr), υ max /cm -1 : 3044, 2974, 2929, 1667, 1599, 1472, 1309, 1247, 1174, 1045, 838, 742, 610; ESI-MS: m/z (%) = 434 (100) [M+Na] + . 化合物3y：粉色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.51 (d, J = 7.6 Hz, 1H), 7.12-7.37 ( m, 7H), 7.00-7.04 (m, 3H), 6.83 (s, 1H), 4.92 (t, J = 8.0 Hz, 1H), 3.74 (s, 3H), 3.54-3.70 (m, 1H), 2.34 ( s, 3H), 2.29 (s, 3H); 13 C NMR (CDCl 3 , 100 MHz):δ (ppm) : 201.35, 144.80, 141.99, 138.65, 137.30, 134.91, 132.90, 132.26, 130.25, 130.05, 129.77, 128.64, 127.35, 126.66, 126.26, 126.15, 121.93, 119.27, 119.08, 116.67, 109.31, 76.68, 47.58, 37.76, 32.74, 21.36, 21.10; IR (KBr), υ max /cm -1 : 3051, 2958, 2917, 1668, 1561, 1466, 1347, 1290, 1199, 1124, 1029, 978, 818, 741, 6890; ESI-MS: m/z (%) = 437 (100) [M+H + ], 458 (93) [M+Na] + . 化合物3z：黄色粉末； 1 H NMR (CDCl 3 , 400 MHz): δ (ppm) : 7.94 (d, J = 1.6 Hz, 1H), 7.70 (dd, J = 12, 2.0 Hz, 1H), 7.45-7.49 (m, 3H), 7.16-7.26 (m, 5H), 7.00-7.09 (m, 5H), 6.79 (s, 1H), 4.94 (t, J = 8.0 Hz, 1H), 3.66-3.73 (m, 3H), 2.18 (s, 3H); 13 C NMR (CDCl 3 , 100 MHz): δ (ppm) : 196.54, 141.27, 137.40, 137.28, 136.68, 136.56, 134.56, 133.13, 130.59, 130.16, 129.69, 129.06, 127.09, 126.86, 126.13, 124.83, 121.71, 119.47, 118.89, 117.73, 109.20, 45.42, 37.78, 32.70, 19.91, 19.34; IR (KBr), υ max /cm -1 : 3085, 3013, 2934, 2891, 1678, 1579, 1463, 1387, 1243, 1197, 1027, 815, 744, 677; ESI-MS: m/z (%) = 458 (100) [M+Na] + ."
"以吲哚和3-(4-甲基苯基)-1-(4-甲氧基苯基)-1-丙酮在乙腈中的反应为模型，对反应条件进行了优化，实验结果见表1。首先考察了催化剂Brønsted酸性离子液体[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]的用量对反应的影响( Table 1 , entries 1-4)。当不加催化剂时，无法得到目标产物( Table 1 , entry 1)。当催化剂用量为15 mol%时，催化效率最高，产率可达98% ( Table 1 , entry 4)，考虑到反应的经济性，确定催化剂的用量为10 mol% ( Table 1 , entry 3)。其次考察了反应时间、溶剂种类等对该反应的影响( Table 1 , entries 5-10)。通过筛选，确定反应的最佳条件为：离子液体催化剂[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]用量10 mol%，乙腈为反应溶剂，反应时间5 h，反应温度80℃。  在最佳反应条件下，对反应底物的普适性进行研究，结果见表2。研究发现α, β-不饱和酮的苯环上连有供电子的Me、Et、OMe或OEt等基团或是吸电子的卤原子时，反应都能够顺利的进行，所得产物产率为82%~99% ( Table 2 , 3b-3l, 3o-3x)。当α, β-不饱和酮的苯环上均为双取代时，也能以优秀的产率得到相应的目标产物( Table 2 , 3m、3y、3z)。此外，无论是吲哚还是N-甲基吲哚都能与各种不同取代的α, β-不饱和酮平稳的反应。以上结果表明，该反应底物的普适性好。"
"在最佳反应条件下，以吲哚和3-(4-甲基苯基)-1-(4-甲氧基苯基)-1-丙酮为模型反应，考察了离子液体 Table 1 Entry Solvent Cat. (mol%) Time (h) Yields (%) b 1 Acetonitrile None 4 0 2 Acetonitrile IL (5) 4 80 3 Acetonitrile IL (10) 4 96 4 Acetonitrile IL (15) 4 98 5 Acetonitrile IL 3 89 6 Acetonitrile IL 5 99 7 Dichloromethane IL 4 80 8 Ethanol IL 4 61 9 Ethyl acetate IL 4 67 10 Toluene IL 4 56 表1. 反应条件优化 a a 反应条件：1a (1 mmol)，2a (1 mmol)，催化剂IL：[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]，溶剂 (5 mL)，80℃； b 分离产率。 Table 2 Entry R 1 R 2 R 3 Yields (%) b Mp (℃) Found Reported 3a H Ph Ph 95 127-128 127-128 [ 21 ] 3b H Ph 4-F- C 6 H 4 99 140-142 142-143 [ 22 ] 3c H Ph 4-Cl-C 6 H 4 92 116-118 118-120 [ 23 ] 3d H Ph 4-OCH 3 -C 6 H 4 94 120-122 124-125 [ 24 ] 3e H 4-Cl-C 6 H 4 Ph 94 155-156 154-155 [ 25 ] 3f H 4-Br-C 6 H 4 Ph 99 173-175 174-176 [ 26 ] 3g H 4-OCH 3 -C 6 H 4 Ph 93 180-181 182-183 [ 25 ] 3h H 4-OCH 3 -C 6 H 4 4-F- C 6 H 4 92 170-172 3i H 4-OCH 3 -C 6 H 4 4-CH 3 - C 6 H 4 92 184-185 183-186 [ 27 ] 3j H 4-OEt-C 6 H 4 3,4-(CH 3 ) 2 -C 6 H 3 86 146-148 3k H 4-OEt-C 6 H 4 3-F-4-Br-C 6 H 3 91 114-116 3l H 4-OEt-C 6 H 4 2-Cl-4-F-C 6 H 3 89 157-159 3m H 3,4-(Cl) 2 -C 6 H 3 3,4-(CH 3 ) 2 -C 6 H 3 88 105-107 3n CH 3 Ph Ph 98 125-126 127-129 [ 28 ] 3o CH 3 Ph 4-F- C 6 H 4 84 161-163 3p CH 3 Ph 4-Cl- C 6 H 4 99 151-155 153-154 [ 29 ] 3q CH 3 Ph 4-Br- C 6 H 4 92 102-104 3r CH 3 Ph 4-OCH 3 - C 6 H 4 93 134-136 130-131 [ 30 ] 3s CH 3 4-Cl-C 6 H 4 Ph 85 135-136 142-143 [ 24 ] 3t CH 3 4-Br-C 6 H 4 Ph 96 138-140 3u CH 3 4-Cl-C 6 H 4 4-OCH 3 - C 6 H 4 82 160-162 3v CH 3 4-Br-C 6 H 4 3,4-(CH 3 ) 2 -C 6 H 3 99 169-171 3w CH 3 4-OEt-C 6 H 4 2-Cl-4-F-C 6 H 3 99 144-145 3x CH 3 4-OEt-C 6 H 4 3,4-(CH 3 ) 2 -C 6 H 3 97 135-137 3y CH 3 2,4-(CH 3 ) 2- C 6 H 3 3,4-(Cl) 2 -C 6 H 3 94 153-154 3z CH 3 3,4-(Cl) 2 -C 6 H 3 3,4-(CH 3 ) 2 -C 6 H 3 86 127-128 表2. 底物的普适性研究 a a 反应条件：吲哚或取代吲哚(1 mmol)，α，β-不饱和酮(1 mmol)，[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ] (10 mol%)，80℃，5 h，乙腈(5mL)。 b 分离产率。 图1. 离子液体[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]的循环性研究 催化剂([ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ])的循环使用效果，结果见图1。具体操作是：将15 mL乙酸乙酯分三次加入到除去粗产物后的滤液中萃取残留的有机物，然后将水相中的水旋除，真空干燥至恒重，即得回收的离子液体催化剂，然后直接用于下一次催化循环实验。研究发现该离子液体催化剂循环使用3次，相应产物的产率分别是95%、90%、88%，表明离子液体具有良好的循环使用效果。"
"本文开展了吲哚和α，β-不饱和酮在Brønsted酸性离子液体[ThiN(CH 2 ) 4 SO 3 ][p-CH 3 PhSO 3 ]催化下的Michael加成反应，以82%~99%的产率合成了β-吲哚酮化合物，具有产物收率高、催化剂可循环使用的特点。"
